WISA TECHNOLOGIES INC
For the period ended Mar 31, 2024. Filed May 20, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 20, 2024
DVLT$0.06+3.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(in thousands)
| | | | | | | |
|---|---|---|---|---|---|---|
| · · Three Months Ended March 31, | ||||||
| · 2024 · 2023 | ||||||
| Cash flows from operating activities: · · | ||||||
| Net income (loss) | | $2,707 | | $(921) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | | | | |||
| Stock-based compensation | | | 380 | | | 499 |
| Depreciation and amortization | | | 20 | | | 33 |
| Amortization of debt discounts | | | 1,260 | | | 719 |
| Change in fair value of warrant liabilities | | | (8,129) | | | (5,604) |
| Changes in operating assets and liabilities: | | | | | ||
| Accounts receivable | | 4 | | 47 | ||
| Inventories | | 158 | | 1,323 | ||
| Prepaid expenses and other current assets | | 35 | | (271) | ||
| Other assets | | | 34 | | | 22 |
| Accounts payable | | 223 | | 137 | ||
| Accrued liabilities | | (229) | | (563) | ||
| Other liabilities | | (3) | | (39) | ||
| Net cash used in operating activities | | (3,540) | | (4,618) | ||
| | | | | | | |
| Cash flows from investing activities: | | | ||||
| Purchases of property and equipment | | (6) | | (14) | ||
| Net cash used in investing activities | | (6) | | (14) | ||
| | | | | | | |
| Cash flows from financing activities: | | | ||||
| Proceeds from issuance of short-term loan, net of issuance costs | | | 600 | | | — |
| Proceeds from issuance of common stock and prefunded warrants, net of issuance costs | | | 11,517 | | | 6,968 |
| Proceeds from exercise of warrants | | | 714 | | | 32 |
| Repurchase of Series B preferred stock and warrants | | | (6,266) | | | — |
| Repayment of finance lease | | | — | | | (6) |
| Repayment of short-term loan | | | (667) | | | — |
| Net cash provided by financing activities | | 5,898 | | 6,994 | ||
| | | | | | | |
| Net increase in cash and cash equivalents | | 2,352 | | 2,362 | ||
| Cash and cash equivalents as of beginning of period | | 411 | | 2,897 | ||
| Cash and cash equivalents as of end of period | | $2,763 | | $5,259 | ||
| | | | | | | |
| Supplemental disclosure of cash flow information: | | | | | | |
| Cash paid for interest | | $272 | | $2 | ||
| Cash paid for income taxes | | $— | | $— | ||
| | | | | | | |
| Noncash Investing and Financing Activities: | | | ||||
| Issuance of warrant liabilities in connection with financing | | $8,701 | | $5,600 | ||
| Deemed dividend on conversion of Series B preferred stock and repurchase of Series B preferred stock | | $5,842 | | $— | ||
| Unpaid financings issuance costs | | $714 | | $— | ||
| Cashless exercise of warrants | | $587 | | $8,170 | ||
| Warrant exercise in connection with loan settlement | | $333 | | $— | ||
| Issuance of common stock in connection with Series B preferred stock | | $325 | | $— | ||
| Issuance of common stock in connection with convertible promissory note | | $— | | $708 | ||
| Deferred offering costs reclassed from prepaid expenses | | $— | | $(97) | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.